Geode Capital Management
MBIO icon

Geode Capital Management’s Mustang Bio MBIO Stock Holding History

Geode Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.5K Buy
92,790
+60,505
+187% +$56.9K ﹤0.01% 4239
2025
Q4 		$31.7K Buy
32,285
+5,867
+22% +$7.75K ﹤0.01% 4318
2025
Q3 		$40.2K Buy
26,418
+10,336
+64% +$18.4K ﹤0.01% 4338
2025
Q2 		$15.4K Buy
16,082
+315
+2% +$381 ﹤0.01% 4394
2025
Q1 		$19.7K Buy
15,767
+10,078
+177% +$38.4K ﹤0.01% 4348
2024
Q4 		$50.3K Buy
5,689
+779
+16% +$8.6K ﹤0.01% 4241
2024
Q3 		$57.8K Buy
4,910
+3,415
+228% +$56.5K ﹤0.01% 4233
2024
Q2 		$35.4K Buy
1,495
+527
+54% +$10K ﹤0.01% 4353
2024
Q1 		$50.3K Sell
968
-28
-3% -$1.78K ﹤0.01% 4318
2023
Q4 		$67.2K Hold
996
– – ﹤0.01% 4281
2023
Q3 		$102K Buy
996
+1
+0.1% +$194 ﹤0.01% 4243
2023
Q2 		$309K Buy
995
+172
+21% +$43.2K ﹤0.01% 3842
2023
Q1 		$226K Hold
823
– – ﹤0.01% 3989
2022
Q4 		$243K Sell
823
-2
-0.2% -$683 ﹤0.01% 3992
2022
Q3 		$290K Hold
825
– – ﹤0.01% 4007
2022
Q2 		$362K Sell
825
-850
-51% -$471K ﹤0.01% 3936
2022
Q1 		$1.27M Sell
1,675
-67
-4% -$55K ﹤0.01% 3503
2021
Q4 		$2.17M Sell
1,742
-53
-3% -$85.6K ﹤0.01% 3328
2021
Q3 		$3.62M Buy
1,795
+183
+11% +$393K ﹤0.01% 3101
2021
Q2 		$4.01M Buy
1,612
+423
+36% +$1.04M ﹤0.01% 3032
2021
Q1 		$2.96M Buy
1,189
+146
+14% +$434K ﹤0.01% 3064
2020
Q4 		$2.96M Buy
1,043
+337
+48% +$805K ﹤0.01% 2871
2020
Q3 		$1.67M Buy
706
+130
+23% +$320K ﹤0.01% 2967
2020
Q2 		$1.37M Buy
576
+35
+6% +$81.8K ﹤0.01% 3032
2020
Q1 		$1.09M Buy
541
+29
+6% +$74.3K ﹤0.01% 2990
2019
Q4 		$1.56M Buy
512
+14
+3% +$32.1K ﹤0.01% 3109
2019
Q3 		$1.22M Sell
498
-30
-6% -$82.1K ﹤0.01% 3162
2019
Q2 		$1.46M Buy
528
+291
+123% +$830K ﹤0.01% 3101
2019
Q1 		$606K Buy
237
+10
+4% +$28.3K ﹤0.01% 3356
2018
Q4 		$500K Buy
227
+9
+4% +$27.4K ﹤0.01% 3375
2018
Q3 		$972K Buy
218
+18
+9% +$90K ﹤0.01% 3232
2018
Q2 		$1.03M Buy
200
+112
+127% +$707K ﹤0.01% 3172
2018
Q1 		$724K Buy
88
+17
+24% +$145K ﹤0.01% 3270
2017
Q4 		$639K Buy
+71
New +$549K ﹤0.01% 3268

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CG
CFO4Life Group Coppell, Texas $656M AUM 17.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Geode Capital Management's MBIO Position: Q1 2026 in Review

Geode Capital Management increased its Mustang Bio (MBIO) stake by 187% in Q1 2026, buying an estimated $56.9K and bringing the position to 92,790 shares worth $67.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4239.

Geode Capital Management first reported a position in MBIO in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.01M in Q2 2021. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Geode Capital Management held 92,790 shares of Mustang Bio worth $67.5K as of Q1 2026.
  • Geode Capital Management bought 60,505 Mustang Bio shares in Q1 2026, an estimated $56.9K.
  • Mustang Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4239 holding.
  • Geode Capital Management first reported a position in Mustang Bio in Q4 2017 and has held it in 34 quarters since.
  • Geode Capital Management's Mustang Bio position peaked at $4.01M in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.